# Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.

> **NCT07297238** · NA · RECRUITING · sponsor: **Jinling Hospital, China** · enrollment: 20 (estimated)

## Conditions studied

- Short Bowel Syndrome (SBS)
- Intestinal Failure

## Interventions

- **DRUG:** GLP-1 Receptor Agonists

## Key facts

- **NCT ID:** NCT07297238
- **Lead sponsor:** Jinling Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-24
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-05-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07297238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07297238, "Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07297238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*